Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data Availability.

Natansh D ModiSandra M SwainMarc BuyseNicole M KudererAndrew RowlandFrank W RockholdMichael J SorichAshley M Hopkins

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)

Unlocking the full potential of clinical trials through comprehensive CSR and IPD sharing can revolutionize cancer care, enhance safety evaluations, and reduce bias in systematic reviews. It is time for all stakeholders to embrace transparency and advance patient-centered outcomes.

Keyphrases

drug administration
clinical trial
electronic health record
systematic review
big data
human health
social media
health information
type diabetes
randomized controlled trial
metabolic syndrome
risk assessment
study protocol
meta analyses
deep learning
adipose tissue
weight loss
drug induced